EDITORIAL
Published on 05 Aug 2022
Editorial: Multi-target directed ligands for the treatment of cancer
doi 10.3389/fonc.2022.980141
- 1,593 views
- 12 citations
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Multi-target Directed Ligands for the Treatment of Cancer
Multi-target Directed Ligands for the Treatment of Cancer
9,124
Total downloads
25k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 27 Apr 2022
Integrated Whole-Transcriptome Profiling and Bioinformatics Analysis of the Polypharmacological Effects of Ganoderic Acid Me in Colorectal Cancer Treatment
doi 10.3389/fonc.2022.833375
- 4,627 views
- 4 citations
ORIGINAL RESEARCH
Published on 30 Mar 2022
Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer
doi 10.3389/fphar.2022.812555
- 1,369 views
- 4 citations
ORIGINAL RESEARCH
Published on 07 Mar 2022
Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer via Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
doi 10.3389/fphar.2021.791269
- 3,546 views
- 23 citations
ORIGINAL RESEARCH
Published on 01 Oct 2021
A Dual PI3K/HDAC Inhibitor Downregulates Oncogenic Pathways in Hematologic Tumors In Vitro and In Vivo
doi 10.3389/fphar.2021.741697
- 2,139 views
- 8 citations
ORIGINAL RESEARCH
Published on 26 Mar 2021
mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2′,4′-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications
doi 10.3389/fonc.2021.656738
- 5,096 views
- 48 citations
Published in
Frontiers in Oncology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore